期刊文献+

抗焦虑抑郁药物与奥美拉唑联合治疗非糜烂性反流病的临床观察 被引量:1

暂未订购
导出
摘要 目的研究探讨对非糜烂性反流病患者采用奥美拉唑联合抗焦虑抑郁药物治疗可以取得的疗效。方法在我院消化科门诊中接受治疗的是非糜烂性反流病患者95例,随机分成对照组46例,治疗组49例,对照组只给予奥美拉唑治疗,治疗组在对照组的基础上,加用抗焦虑抑郁药氟哌塞顿美利曲辛片,观察用药后两组患者的临床体征,比较两组疗效。结果治疗组有效为44例,有效率为89.79%,对照组有效为28例,有效率为62.22%,两组有效率比较P<0.05,存在显著性差异,具有统计学意义。结论非糜烂性反流病与患者的精神心理因素存在一定是相关性,故在治疗时奥美拉唑联合抗焦虑抑郁药物治疗,可以使临床疗效提高。
作者 李胜旭
出处 《中国医学工程》 2011年第12期105-105,107,共2页 China Medical Engineering
  • 相关文献

参考文献6

二级参考文献31

  • 1刘锟,王云杰,范菂,安建东,程庆书,郭仁东.食管胃吻合口的组织学病理学功能学及临床研究[J].中华胸心血管外科杂志,1994,10(1):70-72. 被引量:29
  • 2Calabrese Carlo,Fabbri Anna,Areni Alessandra,Scialpi Carlo,Zahlane Desiree,Di Febo Giulio.Asthma and gastroesophageal reflux disease: Effect of long-term pantoprazole therapy[J].World Journal of Gastroenterology,2005,11(48):7657-7660. 被引量:10
  • 3Bruley des Varannes S, Shi G, Scarpignato C, et al. Sensitivity to acid and distension in gastro-oesophageal refluc disease(GORD) and the acid hypersensitive oesophagus. Gut, 1996, 39 (Suppl 3):A182.?A
  • 4Villanacci V, Grigolato PG, Cestari R, et al. Dilated intercellular spaces as markers of reflux disease: histology, semiquantitative score and morphometry upon light microscopy. Digestion, 2001, 64:1-8.?A
  • 5Johnsson F, Hatlebakk JG, Klintenberg AC, et al. Symptom-relieving effect of esomeprazole 40mg daily in patients with heartburn.Scand J Gastroenterol, 2003, 38:347-353.?A
  • 6Numans ME, Lau J, Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease. Ann Intern Med, 2004, 140:518-527.?A
  • 7Fock KM, Talley N, Hunt R, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol, 2004, 19:357-367.?A
  • 8van Pinxteren B, Numans ME, Bonis PA, et al. Short term treatment with proton pump inhibitor, H2 receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and enddoscopy negative reflux disease. Cochrane Library 2003; 4. Available from URL: http:/www. cochrane. org/cochrane/revabstr/ab002095. htm?A.
  • 9Quigley EM. Factors that influence therapeutic outcome in symptomatic gastroesophageal reflux disease. Am J Gastroenterol, 2003, 98(Suppl 3):S24-S30.?A
  • 10Kahrilas PJ, Quigley EM, Castell DO, et al. The effects of tegaserod (HTF 919) on oesophgeal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther, 2000, 14:1503-1509.?A

共引文献179

同被引文献25

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部